Lyle S, Salhany KE, Elder DE
Prescribing GLP-1 agonists for AUD would constitute off-label use , which requires careful consideration of the evidence base, documented informed consent, clear rationale, appropriate monitoring, and adherence to local governance frameworks
While these GLP-1 medications support significant weight reduction, they also come with unintended aesthetic considerations, such as loose skin, facial volume loss, and body contour irregularities
It also builds scientific depth around TB-500
Please consult your physician, registered dietitian, or other qualified healthcare provider before making changes to your diet or treatment plan